Hanson & Doremus Investment Management Purchases 4,061 Shares of Danaher Corporation $DHR

Hanson & Doremus Investment Management raised its holdings in Danaher Corporation (NYSE:DHR) by 5,414.7% in the third quarter, Holdings Channel.com reports. The fund owned 4,136 shares of the conglomerate’s stock after acquiring an additional 4,061 shares during the period. Hanson & Doremus Investment Management’s holdings in Danaher were worth $916,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in DHR. Veery Capital LLC lifted its position in shares of Danaher by 3.1% during the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after acquiring an additional 48 shares during the last quarter. Studio Investment Management LLC boosted its stake in shares of Danaher by 3.3% during the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after acquiring an additional 51 shares in the last quarter. JDH Wealth Management LLC grew its holdings in shares of Danaher by 4.5% in the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $240,000 after acquiring an additional 55 shares during the last quarter. OLD Second National Bank of Aurora grew its holdings in shares of Danaher by 0.5% in the 1st quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock worth $2,297,000 after acquiring an additional 57 shares during the last quarter. Finally, Adelphi Trust Co grew its holdings in shares of Danaher by 2.5% in the 3rd quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate’s stock worth $524,000 after acquiring an additional 57 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 1.1%

NYSE:DHR opened at $228.87 on Friday. The firm has a market capitalization of $160.89 billion, a price-to-earnings ratio of 40.65, a PEG ratio of 2.91 and a beta of 0.76. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The business’s fifty day moving average price is $214.04 and its 200 day moving average price is $195.97.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the prior year, the business earned $0.77 EPS. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, sell-side analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s payout ratio is currently 28.42%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on DHR shares. Guggenheim upped their target price on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. The Goldman Sachs Group lifted their price target on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. UBS Group began coverage on Danaher in a report on Wednesday, September 9th. They set a “buy” rating and a $250.00 price objective on the stock. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Finally, TD Cowen upped their price objective on shares of Danaher from $236.00 to $255.00 and gave the company a “buy” rating in a research note on Tuesday. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $235.41.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.